Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.

Toshiyasu Taniguchi,Irene Garcia-Higuera,Bo Xu,Paul R Andreassen,Richard C Gregory,Seong-Tae Kim,William S Lane,Michael B Kastan,Alan D D'Andrea

DOI: https://doi.org/10.1016/S0092-8674(02)00747-X

IF: 64.5

2002-01-01

Cell

Abstract:Fanconi anemia (FA) and ataxia telangiectasia (AT) are clinically distinct autosomal recessive disorders characterized by spontaneous chromosome breakage and hematological cancers. FA cells are hypersensitive to mitomycin C (MMC), while AT cells are hypersensitive to ionizing radiation (IR). Here, we identify the Fanconi anemia protein, FANCD2, as a link between the FA and ATM damage response pathways. ATM phosphorylates FANCD2 on serine 222 in vitro. This site is also phosphorylated in vivo in an ATM-dependent manner following IR. Phosphorylation of FANCD2 is required for activation of an S phase checkpoint. The ATM-dependent phosphorylation of FANCD2 on S222 and the FA pathway-dependent monoubiquitination of FANCD2 on K561 are independent posttranslational modifications regulating discrete cellular signaling pathways. Biallelic disruption of FANCD2 results in both MMC and IR hypersensitivity.